Regeneron Pharmaceuticals reported $2.7B in Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Agenus AGEN:US $ 13.7M 0.48M
Agios Pharmaceuticals AGIO:US $ 1.22M 0.7M
Alimera Sciences ALIM:US $ 43.8M 0.2M
Alnylam Pharmaceuticals ALNY:US $ 677.72M 1.01M
Amgen AMGN:US $ 36522M 332M
Astellas Pharma 4503:JP Y 318105M 37255M
AstraZeneca AZN:LN 29528M 1571M
Biogen BIIB:US $ 7277.2M 2M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Bluebird Bio BLUE:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 42060M 2912M
Eli Lilly And LLY:US $ 16813.8M 305M
Esperion Therapeutics ESPR:US $ 259.08M 402K
GlaxoSmithKline GSK:LN 22111M 11217M
Intercept Pharmaceuticals ICPT:US $ 713.86M 3.03M
IONIS PHARMACEUT IONS:US $ 1253.13M 1M
Kyowa Hakko Kirin 4151:JP Y 21873M 864M
Moderna Inc MRNA:US 762M 44M
Neurocrine Biosciences NBIX:US $ 169M 208.7M
Novartis NOVN:VX SF 31031M 244M
Novartis NVS:US $ 31031M 244M
Ophthotech OPHT:US $ 0M 0M
Opthea Ltd OPT:AU 67.25K 45.72K
Puma Biotechnology PBYI:US $ 97.68M 0.3M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M
Seattle Genetics SGEN:US $ 0M 0M
Teva Pharmaceutical TEVA:IT 22.08B 835M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
United Therapeutics UTHR:US $ 800M 0M
Vertex Pharmaceuticals VRTX:US $ 482.3M 13.2M
YTE INCY:US $ 34.19M 0.01M